An in-vivo―in-vitro correlation for the bioavailability of frusemide tabletsKINGSFORD, M; EGGERS, N. J; SOTEROS, G et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 8, pp 536-538, issn 0022-3573Article

Addressing Bioavailability & DigestibilityMERMELSTEIN, Neil H.Food technology (Chicago). 2011, Vol 65, Num 3, pp 76-79, issn 0015-6639, 4 p.Article

Bioavailability of phenolic compoundsKARAKAYA, Sibel.Critical reviews in food science and nutrition. 2004, Vol 44, Num 6, pp 453-464, issn 1040-8398, 12 p.Article

La biodisponibilitéCARON, J; LACROIX, D; LIBERSA, C et al.NPN médecine. 1991, Num 179, pp 524-526, issn 0248-9635Article

Oral bioavailability of flutamide from 1-O-alkylglycerol stabilized o/w nanoemulsionsMADHUSUDHAN, B; RAMBHAU, D; APTE, S. S et al.Journal of dispersion science and technology. 2007, Vol 28, Num 8, pp 1254-1261, issn 0193-2691, 8 p.Article

Increasing bioavailability of iron-fortified foodsTURNER, Elizabeth; BAGRIANSKY, Jack.Food technology (Chicago). 2005, Vol 59, Num 8, pp 74-78, issn 0015-6639, 4 p.Article

Pharmacocinétique: principes fondamentaux = Pharmacokinetics: main principlesLABAUNE, J. P; WEPIERRE, J.1984, 426 p., isbn 2-225-80136-3Book

Nanotechnology for increased micronutrient bioavailabilityJOYE, Iris J; DAVIDOV-PARDO, Gabriel; MCCLEMENTS, David Julian et al.Trends in food science & technology (Regular ed.). 2014, Vol 40, Num 2, pp 168-182, issn 0924-2244, 15 p.Article

Pharmacokinetics and bioavailability of the anti-emetic agent bromoprideBRODIE, R. R; CHASSEAUD, L. F; DARRAGH, A et al.Biopharmaceutics & drug disposition. 1986, Vol 7, Num 3, pp 215-222, issn 0142-2782Article

Circadian changes in carrageenin-induced edema: the anti-inflammatory effect and bioavailability of phenylbutazone in ratsLOUBARIS, N; MICHEL, A; CROS, G et al.Life sciences (1973). 1984, Vol 34, Num 24, pp 2379-2384, issn 0024-3205Article

Enhanced absorption of phenobarbital from suppositories containing phenobarbital povidone coprecipitateIWAOKU, R; OKAMATSU, Y; KINO, S et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 3, pp 1091-1095, issn 0009-2363Conference Paper

Iron-EHPG as an hepatobiliary MR contrast agent: initial imaging and biodistribution studiesLAUFFER, R. B; GREIF, W. L; STARK, D. D et al.Journal of computer assisted tomography. 1985, Vol 9, Num 3, pp 431-438, issn 0363-8715Article

Möglichkeiten zur in-vitro-Beurteilung der Bioverfügbarkeit. IV: Vergleich der Carbamazepinpräparate Finlepsin® und Tegretol® = Evaluation de la biodisponibilité in vitro. IV: comparaison de 2 formes de carbamazépine Finlepsin^® et Tegretol^® = Possibilities of the in vitro evaluation of bioavaibility. IV: comparison of carbamazepine preparations Finlepsin^® and Tegretol^®FÜRST, W; NEUBERT, R; BUCHMANN, E et al.Pharmazie. 1984, Vol 39, Num 3, pp 185-186, issn 0031-7144Article

Correlation between the bioavailability of microencapsulated bacampicillin hydrochloride in suspension and in vitro microcapsule dissolutionSJOVALL, J; SJOQVIST, R; HUITFELDT, B et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 2, pp 141-145, issn 0022-3549Article

Rapid quantitative liquid chromatographic determination of caffeine levels in plasma after oral dosingÓCONNELL, S. E; ZURZOLA, F. J.Journal of pharmaceutical sciences. 1984, Vol 73, Num 7, pp 1009-1011, issn 0022-3549Article

Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpineSAETTONE, M. F; GIANNACCINI, B; CHETONI, P et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 4, pp 229-234, issn 0022-3573Article

Adaptation in human zinc absorption as influenced by dietary zinc and bioavailabilityHUNT, Janet R; BEISEIGEL, Jeannemarie M; JOHNSON, Luann K et al.The American journal of clinical nutrition. 2008, Vol 87, Num 5, pp 1336-1345, issn 0002-9165, 10 p.Article

Speciation and bioavailability of Selenium in yeast-based Intervention agents used in cancer chemoprevention studies : Inductively coupled plasma-mass spectrometryLARSEN, Erik H; HANSEN, Marianne; PAULIN, Helge et al.Journal of AOAC International. 2004, Vol 87, Num 1, pp 225-232, issn 1060-3271, 8 p.Article

Biovailability [Bioavailability] 2001: Bioavailability of Micronutrients in Relation to Human Health: Proceedings of the 4th International Bioavailability Symposium, Interlaken, Switzerland, May 30-June 1, 2001AMADO, Renato; DAVIDSSON, Lena; SOUTHON, Sue et al.International journal for vitamin and nutrition research. 2002, Vol 72, Num 1, issn 0300-9831, 59 p.Conference Proceedings

A comparative study of confidence interval and confidence region methods in determination of bioequivalence between two formulationsHSING-CHU HSU; HAI-LIN LU; CHI, T. C et al.Drug information journal. 1995, Vol 29, Num 3, pp 1021-1028, issn 0092-8615Conference Paper

Area under the curve, bioavailability, and clearance. CommentaryRESCIGNO, A; MARZO, A; BECK, J. S et al.Journal of pharmacokinetics and biopharmaceutics. 1991, Vol 19, Num 4, pp 473-482, issn 0090-466XArticle

Extension of the Loo-Riegelman method to pharmacokinetic data at steady stateNÜESCH, E. A.European journal of clinical pharmacology. 1990, Vol 39, Num 1, pp 55-57, issn 0031-6970, 3 p.Article

Functional determination of antithrombin III in clinical samples and therapeutic concentratesJAWED FAREED; WALENGA, J. M; SVENDSEN, L. G et al.Seminars in thrombosis and hemostasis. 1986, Vol 12, Num 4, pp 328-334, issn 0094-6176Article

Studies on iron availability in man, using stable isotope techniquesFAIRWEATHER-TAIT, S. J; MINSKI, M. J.British journal of nutrition. 1986, Vol 55, Num 2, pp 279-285, issn 0007-1145Article

Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of inputWAGNER, J. G; SZPUNAR, G. J; FERRY, J. J et al.Biopharmaceutics & drug disposition. 1985, Vol 6, Num 2, pp 177-200, issn 0142-2782Article